Life Science Company News

Reset
Results 481 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25

Ethypharm announces the appointment of Éric CHEVALIER as Group Human Resources Director

Read more ››
By: PR Newswire Association LLC. - 04 Oct 2024
Related companies:  Ethypharm Inc.

iD MyStyle® 3 and iD WorkStyle® 3 to Share HOYA's Best Technology Platform Lead by AdaptEase™ Technology

Read more ››
By: PR Newswire Association LLC. - 04 Oct 2024

NMRC Reports Results for Campylobacter Controlled Human Infection Model Study

Read more ››
By: GlobeNewswire - 04 Oct 2024
Related companies:  Immuron Limited

Climb Bio to Present at William Blair’s Upcoming Conference Event on Transforming Autoimmune Diseases by Targeting CD19

Read more ››
By: GlobeNewswire - 04 Oct 2024

Amicus Therapeutics Announces Participation at the World Muscle Society Annual Congress 2024

Read more ››
By: GlobeNewswire - 04 Oct 2024
Related companies:  Amicus Therapeutics, Inc.

Health Canada Approves Label Expansion for Telix’s Illuccix® to Include Patient Selection for PSMA-Targeted Therapy

Read more ››
By: GlobeNewswire - 04 Oct 2024
Related companies:  Telix Pharmaceuticals Limited

Cartesian Therapeutics Announces New Employment Inducement Grants

Read more ››
By: GlobeNewswire - 04 Oct 2024
Related companies:  Cartesian Therapeutics, Inc.

Lifecore Biomedical Raises $24.3 Million in Private Placement of Common Stock

Read more ››
By: GlobeNewswire - 04 Oct 2024
Related companies:  Lifecore Biomedical, LLC

Onco360® Has Been Selected as The National Specialty Pharmacy Partner for Tevimbra® (tislelizumab-jsgr)

Read more ››
By: GlobeNewswire - 04 Oct 2024

Lifecore Biomedical Reports First Quarter of Fiscal 2025 Financial Results and Provides Corporate Update

Read more ››
By: GlobeNewswire - 04 Oct 2024
Related companies:  Lifecore Biomedical, LLC

Humacyte Announces Pricing of $30.0 Million Registered Direct Offering

Read more ››
By: GlobeNewswire - 04 Oct 2024
Related companies:  Humacyte, Inc.

Extendicare Announces Timing of 2024 Third Quarter Results and Conference Call

Read more ››
By: GlobeNewswire - 04 Oct 2024

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: GlobeNewswire - 04 Oct 2024
Related companies:  Taysha Gene Therapies, Inc.

Biodexa Provides Update on Progression Free and Overall Survival in Phase 1 Study of MTX110 in Recurrent Glioblastoma

Read more ››
By: GlobeNewswire - 04 Oct 2024
Related companies:  Biodexa Pharmaceuticals PLC

CytoDyn Engages Syneos Health as CRO For Its Phase II Oncology Trial

Read more ››
By: GlobeNewswire - 04 Oct 2024
Related companies:  CytoDyn, Inc.

Sonnet BioTherapeutics to Receive Non-Dilutive Funding Through New Jersey Tax Certificate Transfer and Australia R&D Tax Incentive Programs

Read more ››
By: GlobeNewswire - 04 Oct 2024
Related companies:  Sonnet BioTherapeutics, Inc.

IO Biotech Announces Two Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting

Read more ››
By: GlobeNewswire - 04 Oct 2024
Related companies:  IO Biotech, Inc.

Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting

Read more ››
By: GlobeNewswire - 04 Oct 2024
Related companies:  Cue Biopharma, Inc.

Werewolf Therapeutics to Present Posters at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting

Read more ››
By: GlobeNewswire - 04 Oct 2024
Related companies:  Werewolf Therapeutics, Inc.

Lyell Immunopharma Announces the Acceptance Abstracts for Presentation at 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Read more ››
By: GlobeNewswire - 04 Oct 2024
Related companies:  Lyell Immunopharma, Inc.
Results 481 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25

Enhance your business development with Biotechgate
Try for free »